2 months Amgen (NASDAQ:AMGN) Stock Rating Reaffirmed by Cantor Fitzgerald MarketBeat
Cantor Fitzgerald reissued an “overweight” rating and set a $405.00 target price on shares of Amgen in a research report on Tuesday.
Amgen (AMGN) · Nasdaq 100 · Science
X